KAIST 생명과학과동창회
  • News & Events
  • News

News

Growing up curious in the countryside leads to tools for manipulating endogenous proteins.

 

 

허원도 교수님 사진.jpg



Won Do Heo

“Good ideas come to me when I am very comfortable, when I am very happy,” says Won Do Heo, who is on the biology faculty at Korea Advanced Institute of Science and Technology (KAIST), and is a neuroscience fellow at the Institute for Basic Science, both in Daejon, Republic of Korea. An idea might come to him in a lab conversation, at a seminar or conference, when he is jogging, on one of his daily walks on a hill, or in the sauna at home.

 

It was a Korean national holiday and Heo was alone in the lab, thinking. He had spent a decade developing and using optogenetic tools. Suddenly, he realized how he might finally turn intrabodies, which are antibodies used to study intracellular proteins, into inducible tools.

 

Heo and his lab converted the idea into two classes of tools to target and manipulate proteins inside cells: optobodies, which can be activated by light; and chemobodies, which can be activated by small molecules. These tools leverage nanobodies, based on camelid antibodies, that are prized in cell biology for being soluble and small they’re around half the size of a green fluorescent protein molecule.

 

During that holiday musing, Heo had figured out at which cysteine residues he could split the nanobody to generate two inactive parts that do not bind a targeted protein. He checked the nanobody structure, and experiments got underway. The split structure lets an experimenter use light to, for example, activate or inhibit a protein at the cell membrane, at an organelle or in the cell nucleus. When the nanobody halves are separate, it’s like having only one chopstick for a meal, he says. Work only gets done when the other half enters the scene.

 

The tools offer high-resolution temporal and spatial information about endogenous proteins, says Heo. With optobodies, light can help with manipulating a targeted protein and thus shape cell function. The team’s chemobody would be good for an in vivo experiment, he says. Such studies, for example in neurobiology, are on his to-do list.

 

The lab used blue light to activate the optobody, but Heo believes he can get the tools to work with infrared light, too. Although there are many types of nanobodies, he believes the tools will work across this antibody class and for many types of questions. The chosen split site is in the antibody’s highly conserved domain.

 

In his lab, says Heo, tool development involves intense testing, which takes a collaborative lab culture. Lab members not involved in a project are a tool’s first users. This arrangement is not easy given his students’ eagerness to publish quickly. But Heo seeks generalizable, broadly applicable tools. “I don’t make very special, very tricky things,” he says, which might only work in a few labs.

 

In his lab, Heo encourages his students to explore projects that intrigue them and that will make them happy during their years in his lab. “If they are not happy with something, I won’t be happy, too.”

 

Heo grew up on a farm in the country. “I didn’t really have the plan to be a professorresearcher at the time,” he says. He played with his dog, rabbit and cows, and was curious about how they interacted and cared for their young. He learned about rice and barley farming. “It’s not textbook, it’s just nature,” he says. In high school, he began breeding birds: peacocks, turkeys, pheasants, parrots and canaries.

 

Even college was not in his plans, but curiosity led him to Gyeongsang National University. “I realized that I had to step up to another level,” he says. Heo studied plant biology and switched to biochemistry in graduate school.

 

For his postdoctoral fellowship, curiosity was again a driver. He wanted to work in mammalian systems, and joined the Duke University lab of Tobias Meyer. Heo followed Meyer to Stanford University where, after a few years, he was promoted to staff researcher. After nine years in California, Heo joined KAIST and chose to focus on optogenetics.

 

Heo feels he can now combine his experience across fields: plant biology, cell biology, cell signaling and neurobiology. As Heo completed his PhD, he remembers realizing that many plant proteins are not present in mammals, which might make them useful tools, he says. This idea has emerged as a cornerstone of optogenetics.

 

Optogenetics has taken cell biology labs beyond observation, which might miss half of the actual cellular events. Cells “are talking to each other, communicating to each other,” he says. The ability to activate or deactivate proteins with light gives labs a way to explore cell biology more deeply and can help them, for example, determine proteins crucial to the cell cycle.

 

“If they are not happy with something, I won’t be happy.”

 

“I admire Won Do’s work for its creativity; he has applied optical control by the cryptochromeCIB1 interaction in very imaginative ways,” says Heo’s friend and colleague, Stanford University researcher Michael Lin. Heo and his students don’t shy away from the hard work necessary to realize their ideas, says Lin. “Developing truly new methods is high-risk and time-consuming, but Won Do has shown that the high rewards make it worth it.”



출처: Nature Methods > This month >

       https://www.nature.com/articles/s41592-019-0626-1


List of Articles
번호 제목 글쓴이 날짜 조회 수
352 정원석 교수님_KAIST, 신경세포의 흥분성 증가로 인한 뇌 질환 기제 규명 생명과학과 2021.06.03 1344
351 정원석 교수님_Astrocytes eat connections to maintain plasticity in adult brains 생명과학과 2020.12.28 1776
350 정원석 교수_ 삼성전자, ‘세계 알츠하이머의 날’ 맞아 연구원 노력 담은 영상 공개 생명과학과 2020.09.21 2589
349 전상용교수님_항암제 표적 단백질을 약물 전달체로 쓴다?​ file 생명과학과 2020.08.26 2884
348 전상용,이대엽 임성갑 교수, 암 줄기세포 제작 원천기술 개발 file 생명과학과 2018.11.30 6712
347 전상용, 송지준 교수님_다양한 변이에도 면역 가능한 인플루엔자 백신 개발 생명과학과 2021.06.30 720
346 전상용 교수님_Researchers review future directions of nanomedicine development 생명과학과 2020.12.28 987
345 전상용 교수님_ 면역항암제 효율 높인 나노입자 백신 개발 file 생명과학과 2020.06.17 3208
344 전상용 교수, 차세대 면역항암제 플랫폼 개발 위한 공동연구협약 체결 / Professor Sangyong Jon, make a research-cooperation contract for developing next-genreation anti-cancer drug platform 관리자 2016.01.08 16109
343 전상용 교수, 암 치료를 위한 새로운 펩타이드-항체 복합체(하이브리드) 기술 개발 file 생명과학과 2019.02.21 6080
342 전상용 교수, 몸 속 물질 이용한 염증 치료제 개발 / Prof. Sang-Yong Jon developed anti-inflammatory drug using biological materials 생명과학과 2016.06.15 19995
341 전상용 교수, Theranostics 저널 최다 피인용 논문상 수상 / Professor Sangyong Jon receives The Most Cited Paper Award by the “Theranostics” Journal 과사무실 2015.04.21 12503
340 전상용 교수, Cancer Research게제(2014.2) 과사무실 2014.03.12 13127
339 전상용 교수, ACS Nano 게재(2014.2) 과사무실 2014.03.12 12660
338 전상용 교수, 94회 일본화학회 정기학회 'Distinguished Lectureship Award' 수상 과사무실 2014.04.02 13028
337 전상용 교수, 2012년도 「글로벌연구실(GRL)」신규 지원과제에 선정! 과사무실 2012.08.17 12554
336 전상용 교수, 2009~2014 기초학문 약학분야 9위 선정 생명과학과 2016.10.04 15901
335 전상용 교수 연구팀, 금 알갱이로 항암백신을 만들다 과사무실 2012.08.17 11745
334 자연과학대학 우수 강의 교원 및 우수 직원 포상 과사무실 2007.03.29 10624
333 임정훈 박사 한국분자・세포생물학회 우수박사학위논문상 수상 과사무실 2004.09.09 14174
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 22 Next
/ 22